Natera Inc NTRA

NAS: NTRA | ISIN: US6323071042 30/01/2026

231,14 USD (-0,15%)

(-0,15%) 30/01/2026

Grafiek Natera Inc

Grafiek Natera Inc

1 dag1d -0,15%
1 week1w -4,25%
1 maand1m 1,01%
3 maanden3m 16,60%
6 maanden6m 71,75%
1 jaar1j 30,91%
5 jaar5j 107,21%

Natera Inc in het nieuws

Toon enkel gratis nieuws

22 januari 2024 · Invitae Completes Sale of Reproductive Health Assets to Natera · Persbericht

21 oktober 2023 · NATERA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. - NTRA · Persbericht

9 december 2022 · Natera Announces Publication of Multi-Center Study Validating Signatera's Ability to Predict Recurrence in Esophageal and Gastric Cancers · Persbericht

7 december 2022 · Natera to Present New Signatera™ and Empower™ Data at the 2022 Annual San Antonio Breast Cancer Symposium · Persbericht

6 december 2022 · Natera Announces Publication of Clinical Experience Study with 18,984 Twin Pregnancies Supporting Excellent Performance of Panorama™ NIPT · Persbericht

23 november 2022 · Natera to Participate in the Piper Sandler 34th Annual Healthcare Conference · Persbericht

21 november 2022 · New Published Study Further Demonstrates the Ability of Natera's mPCR Technology to Monitor Immunotherapy Response in Metastatic Uveal Melanoma Patients · Persbericht

16 november 2022 · Natera Announces Pricing of Follow-On Offering · Persbericht

15 november 2022 · Natera Launches Proposed Follow-On Offering · Persbericht

8 november 2022 · Natera Reports Third Quarter 2022 Financial Results · Persbericht

Profiel Natera Inc

Gezondheidstechnologie

Gezondheidszorg

Gezondheidszorg en sociale bijstand

Medische laboratoria

Medische/verpleegkundige diensten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe